BridgeMD
New treatment option for Androgenetic Alopecia
Official title Six-Month Single-Blind, Placebo-Controlled Study of a Dietary Supplement Supplement on Hair Growth in 45 Volunteers
ClinicalTrials.gov ID: NCT06841458
What this study is testing
- What it's testing
- This clinical study is designed to evaluate the efficacy and safety of a dietary supplement CL-P24113a for the management of androgenetic alopecia (AGA) in male subjects aged 18 to 45 years who suffer from alopecia with low hair density, classified as mild to moderate (Hamilton-Norwood stages II, III, and IV). The product is a formulation based on a blend of botanical ingredients and other well-established compounds, including Pumpkin Seed Oil (Curcubita pepo), Saw Palmetto Oil (Serenoa repens), L-Cystine, Prunus africana Bark Extract (Pygeum africanum), Horsetail Extract (Equisetum arvense), Olive Leaf Extract, among other excipients.
- You might receive a placebo (an inactive treatment) instead of the study drug. You may not know which one you got.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 45, men only
You may be able to join if
- Written consent for LOPD compliance.
- Written informed consent for study DC.506.36.117.
- Gender: Male.
- Age: Between 18 and 45 years.
- Diagnosis of alopecia with low hair density, classified as mild to moderate (stages II, III, and IV on the Hamilton-Norwood scale). Willingness to...
You likely can't join if
- Individuals with gastrointestinal diseases (e.g., diabetes, gastritis, Crohn's disease, celiac disease, ulcers, intolerances, etc.).
- Individuals with other physiological disorders (e.g., diabetes, hypertension, dyslipidemia) and/or gallstones.
- Individuals undergoing medical treatment in the weeks prior to the study that may interfere with study assessments (as determined by the...
- Individuals following an atypical diet or planning to change their dietary routine during the study period.
- Individuals enrolled in another clinical study with similar characteristics (as determined by the investigator) during the study period.
- Individuals who are unable to fully understand the informed consent document or adhere to the study protocol.
See the full eligibility criteria
- Written consent for LOPD compliance.
- Written informed consent for study DC.506.36.117.
- Gender: Male.
- Age: Between 18 and 45 years.
- Diagnosis of alopecia with low hair density, classified as mild to moderate (stages II, III, and IV on the Hamilton-Norwood scale). Willingness to have a 1-2 cm² area shaved throughout the study period.
- Last participation in a clinical study on hair health must have ended at least six months before the start of this study.
- 30-day washout period without specific hair treatments (using a neutral shampoo).
- No use of any other topical or oral hair treatments in the target area during the study period; if necessary, consultation with the principal investigator is required to evaluate continued study participation.
- Individuals with gastrointestinal diseases (e.g., diabetes, gastritis, Crohn's disease, celiac disease, ulcers, intolerances, etc.).
- Individuals with other physiological disorders (e.g., diabetes, hypertension, dyslipidemia) and/or gallstones.
- Individuals undergoing medical treatment in the weeks prior to the study that may interfere with study assessments (as determined by the investigator), particularly those who are currently taking or have taken...
- Individuals following an atypical diet or planning to change their dietary routine during the study period.
- Individuals enrolled in another clinical study with similar characteristics (as determined by the investigator) during the study period.
- Individuals who are unable to fully understand the informed consent document or adhere to the study protocol.
The study team makes the final eligibility decision.
Where it's taking place
- Valencia, Valencia, Spain
- Valencia, Spain
Compensation & support
A stipend or compensation may be offered.
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling male, 18 years to 45 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Valencia, Valencia, Spain; Valencia, Spain. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.